olaratumab
ravulizumab
brolucizumab
immunoglobulin D
ocrelizumab
hemagglutination
sasanlimab
seroprotein
sintilimab
guselkumab
ziltivekimab
heterophilic
vanucizumab
immunospecific
solitomab
retifanlimab
pozelimab
dinutuximab
toripalimab
serofast
zenocutuzumab
immunoprobe
immunoglobulinemia
immunochromatographic
-umab
carlumab
monoantibody
polytypic
-mab
evolocumab
agonistic monoclonal antibody
immunodensity
-a-
antigenic
antiphospholipid antibody
serum globulin
affinity
antimonoclonal
antiantibody
-o-
paraimmunoglobulinopathy
patritumab
immunoenrichment
immunocytometric
hematoimmune
samalizumab
immunocomplexemia
lymphoplasmacytic
serosuitable